Craig T Jordan

This inventor holds 25 USPTO granted patents and 7 published patent applications and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: University of Kentucky Research Foundation, University of Colorado, Bioventures, LLC. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig T Jordan. Retrieved from https://idiyas.com/inventor/craig-t-jordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 7)

% Patents Active = 32.0

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 178(Granted Patents)

Location History:

Lexington, KY (US) (2004 - 2014)
Little Rock, AR (US) (2016)
Rochester, NY (US) (2007 - 2019)
Webster, NY (US) (2014 - 2019)
Denver, CO (US) (2018 - 2019)
Aurora, CO (US) (2016 - 2024)

Company Filing History:

14 out of 903

University of Kentucky Research Foundation

patents

8 out of 1,448

University of Colorado

University of Rochester

patents

5. 2 out of 849

University of Arkansas

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Cancer Stem Cells

AMP-Activated Protein Kinase

STAT3 Inhibitors

Hematologic Cancer

Parthenolide Derivatives

Melampomagnolide B

Cytotoxic Agents

Thiadiazolidinone Derivatives

Organic Cation Transporter

Progenitor Cells

Antileukemic Agents

Cancer Progenitor Cells

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544368 - Compositions and methods for reducing cancer stem cells (2026-02-10),

2. 12435059 - AMP-activated protein kinase inhibitors and methods of making and using the same (2025-10-07),

3. 11952353 - STAT3 transcription factor inhibitors and methods of using the same (2024-04-09),

4. 10508150 - Methods to impair hematologic cancer progenitor cells and compounds related thereto (2019-12-17),

5. 10428082 - Triazole derivatives of melampomagnolide B and methods of use thereof (2019-10-01),

6. 10251890 - Use of parthenolide derivatives as antileukemic and cytotoxic agents (2019-04-09),

7. 10118935 - Melampomagnolide B dimers (2018-11-06),

8. 9981990 - Melampomagnolide B dimers (2018-05-29),

9. 9920063 - Melampomagnolide B derivatives (2018-03-20),

10. 9908892 - Melampomagnolide B derivatives (2018-03-06),

11. 9487536 - Melampomagnolide B derivatives (2016-11-08),

12. 9469650 - Melampomagnolide B derivatives (2016-10-18),

13. 9447112 - Use of parthenolide derivatives as antileukemic and cytotoxic agents (2016-09-20),

14. 9180118 - Thiadiazolidinone derivatives (2015-11-10),

15. 9045490 - Use of parthenolide derivatives as antileukemic and cytotoxic agents (2015-06-02),

Title: The Innovative Journey of Craig T. Jordan

Introduction: Craig T. Jordan, a pioneering inventor hailing from Rochester, NY, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Craig T. Jordan holds several patents in the areas of telecommunications, software development, and renewable energy technologies, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Craig T. Jordan has been recognized for his innovative solutions that have revolutionized various industries. His inventions have not only improved efficiency but have also paved the way for future technological advancements.

Collaborations: Craig T. Jordan has collaborated with leading tech companies, research institutions, and universities to further develop and implement his inventions. His collaborative efforts have resulted in cutting-edge products and solutions that have had a lasting impact on the industry.

Conclusion: In conclusion, Craig T. Jordan's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a visionary inventor in the technological landscape. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.